Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial Active — Not Recruiting Non-phase study NCT07261033

Exploring Equine-Assisted Psychotherapy as an Intervention for Those Who Have Received a Diagnosis of Emotionally Unstable Personality Disorder

Exploring Equine-Assisted Psychotherapy as an Intervention for Those Who Have Received a Diagnosis of Emotionally Unstable Personality Disorder — Active Not Recruiting • Non-phase study • Mental Health…

📅 30 Jun 2026 ⏱ 2 min read
Active — Not Recruiting
Check the registry for current status and eligibility criteria.
Status
Active — Not Recruiting
Phase
Non-phase study
NCT ID
NCT07261033
Start
2026-06-17
Completion
2026-08
ClinicaliQ Trial Snapshot
  • Exploring Equine-Assisted Psychotherapy as an Intervention for Those Who Have Received a Diagnosis of Emotionally Unstable Personality Disorder — Active Not Recruiting • Non-phase study • Mental Health / Psychiatry • NCT07261033.
  • Study testing whether working with horses improves emotional regulation and engagement in inpatients with emotionally unstable personality disorder.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The purpose of this research is for the multi-disciplinary team at an inpatient psychiatric hospital to investigate more innovative ways to engage service users in order to promote wellbeing and emotional regulation. In particular, there is a focus on engaging patients who do not routinely engage with the Psychology Team. As such, we are aiming to explore the effectiveness of Equine Assisted Psychotherapy (EAP) with the service users on a specialist Personality Disorder ward. EAP is the deliberate inclusion of an equine (e.g. horse, alpaca) amongst a therapy team to…

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
Newcastle’s Burn on mental health and importance of asking for help
Mental Health / Psychiatry · BBC Health · 11 May 2026
Community-led mental health initiatives, such as visible environmental prompts (painted benches), can facilitate informal peer conversations and help destigmatise mental health discussions…
View brief →
Guideline
Obsessive-Compulsive Disorder and Body Dysmorphic Disorder (NICE CG31)
Mental Health / Psychiatry · 27 Mar 2026
Diagnose OCD and BDD through systematic assessment of intrusive thoughts, images or impulses combined with repetitive behaviours or mental acts that cause…
View guideline →
Guideline
ADHD: Diagnosis and Management (NICE NG87)
Mental Health / Psychiatry · 27 Mar 2026
Refer suspected ADHD cases (presenting with inattention, hyperactivity, impulsivity, or functional impairment) to specialist services (paediatrician, psychiatrist, or specialist ADHD nurse) for…
View guideline →
Guideline
Bipolar Disorder: Assessment and Management (NICE NG185)
Mental Health / Psychiatry · 27 Mar 2026
Refer urgently to specialist psychiatry if bipolar disorder is suspected; diagnosis must be made by specialists using ICD-10 or DSM-5 criteria For…
View guideline →
Guideline
Ruxolitinib cream for treating non-segmental vitiligo in people 12 years and over
Mental Health / Psychiatry · 17 Mar 2026
Offer ruxolitinib cream as a treatment option for non-segmental vitiligo in patients aged 12 years and over who have involvement of
View guideline →
Clinical Brief
Finasteride and Dutasteride – updated safety warnings for psychiatric side effects and sexual dysfunction
Mental Health / Psychiatry · MHRA · 11 May 2026
The MHRA has identified suicidal thoughts and behaviours as a safety concern with finasteride and dutasteride, requiring additional risk minimisation measures in…
View brief →